Health & Nutrition
NIH funding cuts delayed a promising childhood brain cancer...
A delayed clinical trial underscores the stakes of federal research funding cuts...
Novo is betting on its next chapter as Eli Lilly gains...
As Novo works to turn itself around, some analysts say Lilly has advantages that...
NIH funding cuts delayed a promising childhood brain cancer...
A delayed clinical trial underscores the stakes of federal research funding cuts...
Why we like Starbucks’ latest turnaround move — plus, two...
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon...
Chemotherapy Is Expensive—Is It Effective?
Most chemotherapy drugs are approved by the U.S. Food and Drug Administration (FDA)...
Novo's new strategy hinges on something it can't manufacture:...
Novo has now reached the point where it can broaden its ambitions again, CEO Mike...
Trump administration removes around 760,000 Obamacare enrollments,...
Vice President JD Vance's White House Task Force to Eliminate Fraud estimates the...
How Many Minutes of Life Does a Burger Cost?
If you care about your health so much that it would be unthinkable to light up a...
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients...
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head...
Beauty, health and wellness are converging into one retail...
As consumers prioritize holistic retail purchases, beauty, health and wellness are...
.jpg&h=630&w=1200&q=100&v=c0f97a310e&c=1)
